Skip to main content
HealthBeacon SHA logo

HealthBeacon SHA — Investor Relations & Filings

Ticker · HBCN ISIN · IE00014QAJZ5 LEI · 635400DZJITFJMT8T166 IR Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 54 across all filing types
Latest filing 2024-02-01 Delisting Announcement
Country IE Ireland
Listing IR HBCN

About HealthBeacon SHA

https://healthbeacon.com/

HealthBeacon is a digital therapeutics company specializing in solutions for managing injectable medications. Its core product is the Injection Care Management System (ICMS), a platform designed for patients self-administering medications at home. The system combines a proprietary Smart Sharps Bin with a software application to track medication adherence. By monitoring the disposal of used injections, the ICMS provides personalized reminders, support, and captures behavioral data. This data generates actionable insights for patients and their healthcare providers, facilitating informed clinical decisions and improving treatment persistence. The company's technology has been shown to increase medication adherence rates. The service also features a sustainable component for the re-use and recycling of injection waste.

Recent filings

Filing Released Lang Actions
High Court confirms Scheme of Arrangement
Delisting Announcement Classification · 99% confidence The document is an official announcement disseminated via RNS (RNS Number: 7460B) from HealthBeacon PLC, dated February 1, 2024. The content details the High Court's confirmation of a Scheme of Arrangement, leading to the cancellation of existing shares and the subsequent cancellation of admission to trading on Euronext Growth Markets. This is a significant corporate action announcement regarding capital structure and listing status, but it is not a full financial report (like 10-K or IR), nor is it a standard dividend notice or management change. Since it is a formal regulatory announcement disseminated through the RNS system that details a major corporate event (cancellation of shares/delisting), it fits best under the general 'Regulatory Filings' (RNS) category, as it is a specific, non-standard regulatory update. While it contains elements of a delisting announcement (DLST), the primary mechanism described is the court-confirmed Scheme of Arrangement leading to the cancellation, making RNS the most appropriate general regulatory filing bucket for this type of immediate, material, non-standard corporate event notice.
2024-02-01 English
Update on Examinership
Legal Proceedings Report Classification · 99% confidence The document starts with 'RNS Number : 7166B' and contains standard boilerplate language from RNS, the news service of the London Stock Exchange, including references to the Financial Conduct Authority (FCA). The content is a brief update ('Update on Examinership Process') regarding a court hearing and the potential cancellation of shareholder interests, which is a significant corporate event announcement. Given its brevity (3843 chars) and its nature as a regulatory news service announcement that doesn't fit specific financial reporting categories (like 10-K, ER, or IR), it falls best under the general 'Regulatory Filings' category (RNS) as a miscellaneous regulatory announcement.
2024-02-01 English
Update on Examinership Process
Regulatory Filings Classification · 98% confidence The document is identified by the header 'RNS Number : 5731B' and concludes with information stating, 'This information is provided by RNS, the news service of the London Stock Exchange.' This strongly indicates a regulatory announcement disseminated via the RNS system. The content discusses an 'Update on Examinership Process' and an upcoming court hearing, which is a significant corporate event but does not fit the specific categories like Earnings Release (ER), Annual Report (10-K), or Director's Dealing (DIRS). Since it is a general regulatory announcement that doesn't fit a more specific category (like M&A, Capital Change, or Dividend), the most appropriate classification is the general Regulatory Filings fallback category (RNS). The document length is short (3138 chars), but it is the primary announcement itself, not just an announcement *of* another report, so RPA is less suitable than RNS for this type of legal/procedural update.
2024-01-31 English
Update on Examinership Process
Legal Proceedings Report Classification · 99% confidence The document is identified by the 'RNS Number' header and explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.' The content discusses an 'Update on Examinership Process' involving creditor and member votes and presentation of a report to the High Court. This is a general regulatory announcement concerning a significant corporate/legal event (Examinership process update) that does not fit into the more specific categories like 10-K, ER, or DIV. Therefore, the most appropriate classification is the general regulatory announcement fallback category, RNS.
2024-01-29 English
Update on Examinership Process
Legal Proceedings Report Classification · 99% confidence The document is a short announcement (3641 characters) released via RNS (RNS Number : 1735B) from HealthBeacon PLC on January 29, 2024. It provides an 'Update on Examinership Process,' detailing the voting results from creditor/member meetings and the next steps involving the High Court. This is not a full financial report (like 10-K or IR), nor is it a standard earnings release (ER) or management discussion (MDA). It concerns a specific legal/corporate restructuring event. Since it is a formal, non-standard announcement distributed through the RNS system, and it doesn't fit the specific categories like Director's Dealing (DIRS), Dividend (DIV), or Capital Change (CAP), the most appropriate general regulatory filing category is RNS, which serves as the fallback for miscellaneous regulatory announcements distributed via this channel.
2024-01-29 English
Appointment of Interim Examiner
Legal Proceedings Report Classification · 99% confidence The document is identified by the RNS Number (5938R) and explicitly states it is provided by RNS, the news service of the London Stock Exchange, which acts as a Primary Information Provider. The content announces a significant legal/financial event: the presentation of a Petition for Examinership (a form of insolvency protection/restructuring under Irish law) and the appointment of an Interim Examiner. This type of announcement, which details legal proceedings, restructuring efforts, and the suspension of trading, is a critical regulatory disclosure. While it relates to financial distress (which could touch upon CAP or LTR), the format and source (RNS) strongly suggest a general regulatory announcement. Since it is a specific, material event announcement distributed via the official regulatory news service, and it doesn't fit perfectly into the other specific categories (like 10-K, ER, or DIV), the most appropriate general category for material regulatory news distributed via RNS is 'Regulatory Filings' (RNS). The document length is short (4047 chars), but it is the primary disclosure itself, not an announcement *about* another report.
2023-10-27 English

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.